95% CI, 0.76-0.94), gestational diabetes (15.2% vs
Biological mechanisms explain why lower-dose strategies may still produce metabolic effects
All GLP-1RAs retain the capacity to activate the GLP-1 receptor (GLP-1R), thereby initiating intracellular signaling cascadesincluding cAMP accumulation, protein kinase A (PKA) activation, and PI3K/Akt pathway engagementunderlying their endocrine, metabolic, and neuroprotective effects [8]
It works by replicating the bodys natural hormone GLP-1, which is responsible for regulating appetite, digestion, and blood sugar balance
The proposed mechanisms by which GLP-1 receptor agonists might influence pancreatic health involve several biological pathways, though none have been conclusively proven to cause pancreatitis in humans
Dr Toby Pillinger, an Academic Clinical Lecturer at Kings IoPPN and the studys senior author said, Living with obesity and diabetes can take a significant toll on both physical and emotional well-being
00188-2/asset/060af149-96d8-44a2-9e4d-318ecc8ae69e/main.assets/gr1_lrg.jpg)
